Related Experiment Videos
Heparin-associated thrombocytopenia treatment with low molecular weight heparin
Thrombosis and Haemostasis
|February 28, 1986
Abstract:
Eight patients with heparin associated thrombocytopenia (HAT) were treated by a low molecular weight heparin derivative (LMW). Biological and clinical improvement occurred in all patients. This efficiency confirms the antithrombotic activity of LMW and allows its use in patients with HAT.